Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Repetto

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Nanotechnology|March 12, 2010
DNA-functionalized solid state nanopore for biosensingV Mussi, P Fanzio, L Repetto, et al.
Oncology|January 1, 1988
Radioimmunoimaging in malignant melanoma with monoclonal antibodiesL Repetto, G Scopinaro, A Michelotti, et al.
Giornale Italiano Di Chemioterapia|January 1, 1985
[Evaluation of 4-demethoxydaunorubicin toxicity (IMI 30). Preliminary data]M T Nobile, P Pronzato, E Campora, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1992
Chemotherapy-induced amenorrhea and other clinical and pathological parameters in the prognosis of breast cancer patientsS Toma, L Repetto, A Giacchero, et al.
Minerva Chirurgica|April 15, 1988
[Current diagnostic and therapeutic trends in recalcitrant hemoptysis]M Taviani, R M Lo Casto, P M Fuliano, et al.
Hematological Oncology|July 1, 1986
Aggressive angiofollicular lymph node hyperplasia (Castleman's disease) treated with high dose melphalan and autologous bone marrow transplantationL Repetto, M P Jaiprakash, P J Selby, et al.
Minerva Chirurgica|May 31, 1989
[Primary tumors of the biliary hilum. Anatomical and therapeutic aspects]N Morelli, L Repetto, M Taviani, et al.
Gynecologic Oncology|September 1, 1990
Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second lookM Bruzzone, L Repetto, S Chiara, et al.
Tumori|June 30, 1990
Prognostic factors in stage IV ovarian carcinoma treated with platinum-based regimensL Repetto, S Chiara, M Pace, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1991
Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancerS Chiara, M Orsatti, P Franzone, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Nanotechnology|March 12, 2010
DNA-functionalized solid state nanopore for biosensingV Mussi, P Fanzio, L Repetto, et al.
Oncology|January 1, 1988
Radioimmunoimaging in malignant melanoma with monoclonal antibodiesL Repetto, G Scopinaro, A Michelotti, et al.
Giornale Italiano Di Chemioterapia|January 1, 1985
[Evaluation of 4-demethoxydaunorubicin toxicity (IMI 30). Preliminary data]M T Nobile, P Pronzato, E Campora, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1992
Chemotherapy-induced amenorrhea and other clinical and pathological parameters in the prognosis of breast cancer patientsS Toma, L Repetto, A Giacchero, et al.
Minerva Chirurgica|April 15, 1988
[Current diagnostic and therapeutic trends in recalcitrant hemoptysis]M Taviani, R M Lo Casto, P M Fuliano, et al.
Hematological Oncology|July 1, 1986
Aggressive angiofollicular lymph node hyperplasia (Castleman's disease) treated with high dose melphalan and autologous bone marrow transplantationL Repetto, M P Jaiprakash, P J Selby, et al.
Minerva Chirurgica|May 31, 1989
[Primary tumors of the biliary hilum. Anatomical and therapeutic aspects]N Morelli, L Repetto, M Taviani, et al.
Gynecologic Oncology|September 1, 1990
Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second lookM Bruzzone, L Repetto, S Chiara, et al.
Tumori|June 30, 1990
Prognostic factors in stage IV ovarian carcinoma treated with platinum-based regimensL Repetto, S Chiara, M Pace, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1991
Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancerS Chiara, M Orsatti, P Franzone, et al.
Pageof 13